Lonza Group stock holds 619.20 EUR as rebound extends
Published on 08/21/2026 at 17:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lonza Group stock (CH0013841017) traded at 619.20 EUR on August 20, 2026, with a five-day gain of 2.93% and a year-to-date decline of 1.96%, while market value stood at CHF 39.47 billion.
Market setup
The latest market snapshot shows a rebound inside a still softer 2026 trend, and that mix matters more than the headline price alone. A share price of 619.20 EUR against a market cap of CHF 39.47 billion leaves Lonza in large-cap territory even after the year-to-date pullback.
That same snapshot also gives the stock a concrete comparison point: the five-day move is positive at 2.93%, but the year-to-date figure remains negative at 1.96%. For investors, that gap says the recent recovery has not yet erased the broader 2026 weakness.
Latest reported figures
In the current coverage set, H1 2026 revenue was 116.7 million and gross profit was 72.6 million, while revenue growth reached 10.5% year over year. The same source also said 2026 organic sales growth is guided at 7% to 8% and adjusted EBITDA margin is expected at the upper end of 37% to 38%.
Those numbers matter because they frame the stock against actual operating momentum rather than a pure market move. A 10.5% revenue increase alongside a 37% to 38% margin target points to a business still focused on profitable growth rather than volume alone.
What the product says
Lonza's contract development and manufacturing work remains the key commercial driver, with biologics services and specialized production capacity carrying the company's investor case. The market is still valuing that mix of recurring demand and high-specification manufacturing at CHF 39.47 billion.
Share level to watch
The stock's 619.20 EUR level on August 20, 2026 leaves it below a fresh breakout zone, but the short-term trend has improved. The combination of a 2.93% five-day rise and a 1.96% year-to-date decline shows a stock that has bounced without fully changing its 2026 profile.
Fact box
Company: Lonza Group Ltd.
ISIN: CH0013841017
Ticker: LONN
Exchange: SIX Swiss Exchange
Price (as of August 20, 2026): 619.20 EUR
Market cap: CHF 39.47 billion (as of August 20, 2026)
Sector / Industry: Biotechnology / Medical research
